Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

PHOX2B PC-CAR T Cells for Relapsed Neuroblastoma — Stella

Home/Refractory Neuroblastoma/PHOX2B PC-CAR T Cells for Relapsed Neuroblastoma

View on ClinicalTrials.gov

Recruiting

Back to Refractory Neuroblastoma trials

PHOX2B PC-CAR T Cells for Relapsed Neuroblastoma

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Key details

Phase

Early testing

Sponsor

Stephan Grupp MD PhD

Collaborators

Children's Hospital of Philadelphia, Alliance for Cancer Gene Therapy

Enrollment target

~38 participants

Started

June 2025

Primary completion

June 2032

Age range

1 Year and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.